ACESO continues to build a scientific foundation for a new generation of cystic fibrosis therapy focused on patients underserved by current treatment options.
ACESO Therapeutics is advancing a therapeutic strategy designed to address meaningful gaps in cystic fibrosis care. While current modulators have changed the treatment landscape for many patients, significant unmet needs remain for those who are underserved by existing approaches.
A research-led approach to cystic fibrosis innovation
“To bring transformative therapy to every cystic fibrosis patient, we need innovation that reaches beyond the limits of current treatment options.”
Building for patients without options
ACESO’s pipeline is focused on patients who may not benefit adequately from currently available therapies. By targeting areas of continued unmet need, the company aims to support a broader and more inclusive future for cystic fibrosis treatment.
Next steps
As the company continues to advance its platform, ACESO will share selected updates related to research milestones, pipeline progress, scientific presentations, and partnership development.